Herbert Irving Comprehensive Cancer Center

News, plus New Perspectives on the War Against Cancer

www.nypcancerprevention.org <http://www.nypcancerprevention.org> 

Cancer Prevention is published twice a year by the Cancer Prevention Program at the NewYork-Presbyterian Hospital, New York City

***********

Global Trends in Cancer Occurrence: Priorities for Cancer Prevention

Aging populations, increased smoking rates and the adoption of unhealthy Western diets and lifestyle don't bode well for cancer rates in the developing world, warns the American Cancer Society's Dr. Michael Thun and others, in our cover article. On the other hand, interventions such as aggressive vaccination campaigns against hepatitis B and HPV, along with effective public education, could help put the brakes on an emerging worldwide cancer disaster, these experts say.

***********

Issues & Insights: The Argument For and Against CT Colonography

Is CT colonography a reliable, less invasive form of colon screening that could get millions more Americans in for testing, or is it an unproven technology that could raise radiation exposures but not screening rates? Two experts -- New York University's Dr. Michael Macari and Indiana University's Dr. Douglas Rex -- debate this contentious issue from the Pro and Con sides, respectively.

*************

Harvesting Nature's Bounty for Cancer Prevention

Resveratrol from grapes (and red wine), sulphoraphane from crunchy vegetables such as broccoli, and compounds found in a variety of sea flora are all showing great promise as cancer-preventing agents. In his thoughtful essay, the University of Hawaii's Dr. John Pezzuto elaborates on the insights his lab is making into Mother Nature's own cancer-fighting pharmacopoeia.

*************

Pioneers in Cancer Prevention from the Worlds of Science and Philanthropy 

In two profile articles, Cancer Prevention spotlights leading lights in the war against cancer: 

First, a focus on Dr. Frank L. Meyskens, Jr., whose pioneering work in retinoids, DFMO and other cancer-preventing agents has brought him international acclaim.  Then, a profile of financier, philanthropist and prostate cancer survivor Michael Milken, whose business-model approach to prostate cancer research has led to hundreds of millions of dollars in new funding, better public awareness of the disease, and numerous scientific breakthroughs over the past two decades.

**************

PLUS: in News From The NCI, a breakthrough study finds that a key change in blood cells occurring years earlier can predict the onset of multiple myeloma;  a round-up of new statistics showing that as cancer retreats in the U.S. it is on the rise internationally;  a major study suggesting that daily use of NSAID painkillers might lower breast cancer risk; and the launch of the Love/Avon Army of Women campaign, which aims to link up thousands of female volunteers with the breast cancer researchers who need them.

Also, our usual updates on scientific meetings and clinical trials and a listing of cancer-focused state and national legislative initiatives.

To provide feedback, order hard copies or to post our newsletter URL on your website, please contact: 212-305-9074 or atb2002@nyp.org

To stop receiving newsletter announcements twice per year from the Cancer Prevention Program, please email atb2002@nyp.org with "remove” or “unsubscribe" in the subject line.